首页> 外国专利> FOERFARANDE Før FRAMSTAELLNING TERAPEUTISKT ANVAENDBARA of the AV-5-TETRAZOLYL) -1-OXO-1H-TIAZOLO (3,2-a) pyrimidine-2-carboxylate ATR

FOERFARANDE Før FRAMSTAELLNING TERAPEUTISKT ANVAENDBARA of the AV-5-TETRAZOLYL) -1-OXO-1H-TIAZOLO (3,2-a) pyrimidine-2-carboxylate ATR

机译:从理论上讲,AV-5-四唑基-1-OXO-1H-噻唑(3,2-a)嘧啶-2-羧酸酯ATR的制备方法在治疗上适用

摘要

Antiallergy and antiulcer agents having the formula (I), IMAGE and their pharmaceutically acceptable salts, wherein R1 and R2 taken separately are each hydrogen or C1-5 alkyl; and R1 and R2 taken together are alkylene of 3 - 9 carbon atoms or phenylalkylene of 9 - 11 carbon atoms, with the proviso that the ring so formed is between 5- and 8-membered; acids of the formula (II), IMAGE wherein R1 and R2 are as defined above and R3 is hydrogen, which are useful as intermediates for compounds of the formula (I), but in many instances also possess the same useful biological activity as do formula I compounds; and intermediates of the formula II wherein R1 and R2 are defined as above, and R3 is alkyl of 1 to 4 carbon atoms, carbalkoxy of 2 to 5 carbon atoms, carbophenoxy or carbobenzoxy, are described.
机译:具有式(I),的抗过敏和抗溃疡药及其药学上可接受的盐,其中R 1和R 2分别是氢或C 1-5烷基; R 1和R 2一起是3-9个碳原子的亚烷基或9-11个碳原子的亚苯基,但条件是这样形成的环在5-8元之间。式(II)的酸,其中R 1和R 2如上所定义且R 3是氢,其可用作式(I)的化合物的中间体,但在许多情况下还具有与式(I)的化合物相同的有用的生物学活性。做式I化合物;描述了式II的中间体,其中R 1和R 2如上所定义,且R 3是1-4个碳原子的烷基,2-5个碳原子的烷氧基,羧苯氧基或羧苯甲酰基。

著录项

  • 公开/公告号FI67706B

    专利类型

  • 公开/公告日1985-01-31

    原文格式PDF

  • 申请/专利权人 PFIZER INC;

    申请/专利号FI19800003628

  • 发明设计人 KADIN SAUL BERNARD;

    申请日1980-11-21

  • 分类号C07D513/04;C07D257/06;

  • 国家 FI

  • 入库时间 2022-08-22 08:16:35

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号